SwedenBIO and the EBD Group Collaborate
News May 07, 2013
EBD Group and SwedenBIO announces its collaboration at Nordic Life Science Days 2013 in Stockholm, Sweden, where EBD will provide partneringONE as a partnering solution for the life sciences and is the industry's most advanced collaboration software.
Nordic Life Science Days, to be held October 14–15, 2013, is an international partner-, invest- and network meeting organized by SwedenBIO, a leading trade association for the Scandinavian life science sector, along with its sister organizations in Denmark, Finland and Norway—Biopeople, the Finnish Bioindustries and Norwegian BioIndustry Association.
“Nordic Life Science Days is an important event for our region and our members. partneringONE will allow attendees to participate in partnering using the most effective networking platform available in the industry.” said Dr. Jonas Ekstrand, acting CEO of SwedenBIO. “We have chosen the EBD Group based on the reputation of their products and the positive feedback we have received from leaders in the industry.”
"We are very excited to be on board with SwedenBIO to provide partneringONE at the Nordic Life Science Days event,” said Carola Schropp, President of EBD Group. “We believe partneringONE is uniquely positioned to facilitate highly productive partnering that will result in new collaborative opportunities, licensing deals and innovative drug development agreements for life science companies in the Northern European sector."
partneringONE facilitates one-to-one meetings to take place at the event between companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups. Meetings are scheduled prior to the event and delegates can manage their schedules online. Up to 20 life science events each year rely on the robust platform of partneringONE, provided as a third-party service.
The system generates over 40,000 one-to-one meetings annually at EBD Group's six life science partnering events held around the world. With partneringONE, pharma and biotech dealmakers can create a partnering profile and begin efficiently identifying and requesting meetings with potential collaborators.
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.READ MORE